Gout Disease Treatment Market Report 2024 (Global Edition)

Global Gout Disease Treatment Market Report 2024 Market Size Split by Drug Class (NSAIDs, Corticosteroids, Colchicine, Urate-Lowering Agents, Others), by Disease Condition (Acute Gout, Chronic Gout), ...

Gout Disease Treatment Market Report Description

We have various report editions of Gout Disease Treatment Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Gout Disease Treatment Market Insights Video

Competitive Landscape of the Gout Disease Treatment Market

The competitive landscape of the Gout Disease Treatment Market is characterized by a mix of established pharmaceutical companies and emerging biotech firms, each striving to innovate and capture market share through novel therapies. Collaborations and strategic partnerships are increasingly common as companies seek to enhance their product offerings and expand their reach in this evolving market.

In July 2024, Takeda reported its earnings for the first quarter of fiscal year 2024, ending June 30, 2024. The company experienced ongoing growth in its Growth & Launch Products, which contributed positively to core growth at constant exchange rates (CER), effectively compensating for the revenue decline caused by substantial losses of exclusivity from the prior fiscal year. (Source: https://www.takeda.com/newsroom/newsreleases/2024/takeda-announces-first-quarter-fy2024-results/) In May 2024, AstraZeneca Pharma India Ltd., a science-driven biopharmaceutical firm, is excited to report strong financial results for the fiscal year ending March 31, 2024. The company recorded a total revenue of INR 1,330 crore, reflecting an impressive 29% increase in revenue. (Source: https://www.astrazeneca.in/media/press-releases/2024/AstraZeneca-Pharma-India-Limited-achieves-growth-of-29-percentage-for-financial-year-ended-March-31-2024.html) In October 2023, Amgen officially finalized its acquisition of Horizon Therapeutics plc, purchasing shares at $116.50 each in cash, which equates to a total transaction equity value of around $27.8 billion. (Source: https://www.prnewswire.com/news-releases/amgen-completes-acquisition-of-horizon-therapeutics-plc-301949517.html)

Top Companies Market Share in Gout Disease Treatment Industry: (In no particular order of Rank)

• Novartis AG
• Takeda Pharmaceutical Company Limited
• AstraZeneca
• Horizon Therapeutics plc
• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Mylan N.V.
• Sandoz International GmbH
• UCB S.A.
• Ridgeback Biotherapeutics
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Gout Disease Treatment Market

Which Region Dominates the Gout Disease Treatment Market in 2024?

According to Cognitive Market Research, the North American region dominates the Gout Disease Treatment Market due to its advanced healthcare infrastructure, high prevalence of gout, and significant investments in research and development. Additionally, the availability of innovative treatments and a strong focus on patient education further bolster market growth in this region.

Which Region is Expanding at the Fastest CAGR?

Europe is the fastest-growing region in the Gout Disease Treatment Market, driven by increasing awareness of gout management and rising healthcare expenditures. The region is also witnessing a growing number of clinical trials and the introduction of novel therapies, contributing to its rapid expansion.

The current report Scope analyzes Gout Disease Treatment Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Gout Disease Treatment

According to Cognitive Market Research, the global Gout Disease Treatment Market size was estimated at USD 2681.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1072.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.

• According to Cognitive Market Research, the U.S. had a major share in the Gout Disease Treatment Market with a market size of USD 846.19 million in 2024 and is projected to grow at a CAGR of 6.8% during the forecast period. The United States leads the Gout Disease Treatment Market due to its advanced healthcare infrastructure and high prevalence of gout among its population.
• The Canada Gout Disease Treatment Market had a market share of USD 128.70 million in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period. Canada is witnessing rapid growth in the gout treatment market, driven by increased awareness and access to innovative therapies.
• The Mexico Gout Disease Treatment Market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 97.60 million in 2024.

Europe Gout Disease Treatment

According to Cognitive Market Research, the global Gout Disease Treatment Market size was estimated at USD 2681.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 804.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.

• The United Kingdom Gout Disease Treatment Market had a market share of USD 135.13 million in 2024 and is projected to grow at a CAGR of 8.1% during the forecast period. The U.K. is the fastest-growing country in the Gout Disease Treatment Market, driven by enhanced healthcare initiatives and increased patient awareness about gout management and treatment options.
• The France Gout Disease Treatment Market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 74.00 million in 2024.
• According to Cognitive Market Research, the German Gout Disease Treatment Market size was valued at USD 159.26 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. Germany is the dominant country in the European Gout Disease Treatment Market, thanks to its robust healthcare system and extensive pharmaceutical availability.
• The Italy Gout Disease Treatment Market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 69.17 million in 2024.
• The Russia Gout Disease Treatment Market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 124.68 million in 2024.
• The Spain Gout Disease Treatment Market is projected to witness growth at a CAGR of 6.4% during the forecast period with a market size of USD 65.96 million in 2024
• The Luxembourg Gout Disease Treatment Market is projected to witness growth at a CAGR of 7.4% during the forecast period, with a market size of USD 24.94 million in 2024.
• The Portugal Gout Disease Treatment Market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 16.89 million in 2024.
• The Greece Gout Disease Treatment Market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 9.65 million in 2024.
• The Rest of Europe's Gout Disease Treatment Market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 124.68 million in 2024.

Asia Pacific Gout Disease Treatment

According to Cognitive Market Research, the global Gout Disease Treatment Market size was estimated at USD 2681.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 616.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.8% from 2024 to 2031.

• According to Cognitive Market Research, the China Gout Disease Treatment Market size was valued at USD 277.50 million in 2024 and is projected to grow at a CAGR of 10.3% during the forecast period. China is the dominant country in the Gout Disease Treatment Market due to its vast population and increasing prevalence of gout, coupled with significant investments in healthcare infrastructure and access to innovative therapies.
• The Japan Gout Disease Treatment Market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 85.10 million in 2024.
• The India Gout Disease Treatment Market had a market share of USD 74.00 million in 2024 and is projected to grow at a CAGR of 12.6% during the forecast period. India is the fastest-growing country in this region, driven by improving healthcare access and increasing prevalence of gout .
• The South Korean Gout Disease Treatment Market is projected to witness growth at a CAGR of 9.9% during the forecast period, with a market size of USD 61.67 million in 2024.
• The Australian Gout Disease Treatment Market is projected to witness growth at a CAGR of 10.5% during the forecast period, with a market size of USD 32.07 million in 2024.
• The South East Asia Gout Disease Treatment Market is projected to witness growth at a CAGR of 11.8% during the forecast period, with a market size of USD 42.55 million in 2024.
• The Rest of Asia Pacific Gout Disease Treatment Market is projected to witness growth at a CAGR of 10.6% during the forecast period, with a market size of USD 43.78 million in 2024.

South America Gout Disease Treatment

According to Cognitive Market Research, the global Gout Disease Treatment Market size was estimated at USD 2681.2 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 134.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Gout Disease Treatment Market size was valued at USD 57.38 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. Brazil is the dominant country in the Latin American Gout Disease Treatment Market, owing to its large population and healthcare advancements.
• Argentina's Gout Disease Treatment Market had a market share of USD 22.52 million in 2024 and is projected to grow at a CAGR of 9.1% during the forecast period. Argentina is the fastest-growing country in the Gout Disease Treatment Market, driven by rising healthcare investments and increased awareness of gout management among the population.
• Colombia's Gout Disease Treatment Market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 11.93 million in 2024.
• Peru Gout Disease Treatment Market is projected to witness growth at a CAGR of 8.4% during the forecast period, with a market size of USD 10.99 million in 2024.
• Chile's Gout Disease Treatment Market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 9.65 million in 2024.
• The Rest of Latin America's Gout Disease Treatment Market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 21.58 million in 2024.

Middle East and Africa Gout Disease Treatment

According to Cognitive Market Research, the global Gout Disease Treatment Market size was estimated at USD 2681.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 53.62 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.

• The GCC Countries Gout Disease Treatment Market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 22.95 million in 2024. The United Arab Emirates is the dominant country in the GCC for the Gout Disease Treatment Market, attributed to its advanced healthcare infrastructure and high healthcare spending.
• The Egypt Gout Disease Treatment Market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 5.63 million in 2024.
• The South Africa Gout Disease Treatment Market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 8.47 million in 2024. South Africa is the fastest-growing country in the Gout Disease Treatment Market, driven by increasing healthcare access and awareness of gout management among the population.
• The Turkey Gout Disease Treatment Market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 4.61 million in 2024.
• The Nigeria Gout Disease Treatment Market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 5.63 million in 2024.
• The Rest of the MEA Gout Disease Treatment Market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 6.33 million in 2024.

Gout Disease Treatment Market Analysis

Gout Disease Treatment Market Drug Class Segment Analysis

According to Cognitive Market Research, Urate-Lowering Agents (ULAs) dominate the Gout Disease Treatment Market due to their effectiveness in reducing uric acid levels and preventing gout attacks. Medications such as allopurinol and febuxostat are widely prescribed for chronic gout management, leading to significant adoption among healthcare providers. The growing awareness of gout's long-term complications and the need for effective management strategies have further solidified ULAs as the preferred treatment choice for patients, contributing to their dominant market share.

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) are the fastest-growing category in the Gout Disease Treatment Market. Their role in providing rapid relief from acute gout flare-ups has increased their usage significantly. As more patients seek immediate pain management solutions, the demand for NSAIDs continues to rise. Additionally, the expansion of over-the-counter options and the promotion of NSAIDs as first-line therapies for acute attacks are driving this growth, making them a key segment in the evolving landscape of gout treatments.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Gout Disease Treatment Industry. Request a Free Sample PDF!

Gout Disease Treatment Market Disease Condition Segment Analysis

According to Cognitive Market Research, the Acute Gout segment is the dominant category in the Gout Disease Treatment Market, primarily due to the high incidence of acute flare-ups among patients. Acute gout attacks can be extremely painful and prompt immediate treatment, leading to a consistent demand for medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and colchicine. The prevalence of lifestyle factors that trigger acute gout episodes, such as diet and obesity, further drives the market for treatments aimed at rapid relief from symptoms.

The Chronic Gout segment is the fastest-growing category in the Gout Disease Treatment Market as awareness of long-term management strategies increases among healthcare providers and patients. The focus on preventative care and the use of urate-lowering therapies are contributing to this growth. As more patients are diagnosed with chronic gout, there is a growing demand for effective long-term treatment options that can help prevent future flare-ups and manage uric acid levels more effectively.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Gout Disease Treatment Distribution Channel Segment Analysis

Gout Disease Treatment Market Distribution Channel Segment Analysis

According to Cognitive Market Research, the Hospital Pharmacy segment dominates the Gout Disease Treatment Market, primarily due to the high volume of gout patients receiving treatment in healthcare facilities. Hospitals often have direct access to a range of specialized medications and therapies that cater to gout management, making them the preferred choice for healthcare providers. The presence of healthcare professionals who can guide treatment decisions also enhances patient adherence and improves outcomes, solidifying the position of hospital pharmacies in this market.

The Online Pharmacy segment is the fastest-growing category in the Gout Disease Treatment Market, driven by the increasing shift toward e-commerce and the convenience of home delivery. As patients seek more accessible treatment options, online pharmacies offer competitive pricing and the privacy of purchasing medications without visiting a physical store. The rise in telemedicine and online consultations has further accelerated this trend, enabling patients to manage their gout treatment more efficiently and fostering the growth of the online pharmacy sector.

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion